Ask AI
Bill117th CongressFiled Nov 18, 2021Crime and Law Enforcement
S. 3257

A bill to amend the Controlled Substances Act to lengthen the period of time during which certain controlled substances must be administered to a patient after being delivered by a pharmacy to the administering practitioner.

Bill journey · stage 2 of 5

Under committee review

Filed
Comm.
Floor
Both
Law

What it doesSummary introduced in senate (Nov 18, 2021)

This bill increases the number of days—from 14 to 60—within which a practitioner must administer certain narcotic drugs (e.g., buprenorphine) to a patient for maintenance or detoxification treatment (i.e., substance use disorder treatment) after receiving the drugs from a pharmacy. Additionally, the bill revises the process by which the Department of Justice may modify the number of days within which such drugs must be administered.

What just happenedNov 18, 2021

Read twice and referred to the Committee on the Judiciary.

Who’s behind it

Sen. Shaheen, Jeanne [D-NH](D-NH)Sponsor
1 cosponsor1 R
Read on Congress.gov
1cosponsors1committees2actions1related bills
  1. Nov 18, 2021IntroReferral

    Read twice and referred to the Committee on the Judiciary.

    Judiciary Committee
  2. Nov 18, 2021IntroReferral10000

    Introduced in Senate

A bill to amend the Controlled Substances Act to lengthen the period of time during which … — Informed